BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26305882)

  • 1. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
    Pavicic W; Perkiö E; Kaur S; Peltomäki P
    Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.
    Purkait S; Sharma V; Kumar A; Pathak P; Mallick S; Jha P; Sharma MC; Suri V; Julka PK; Suri A; Sharma BS; Sarkar C
    Exp Mol Pathol; 2016 Apr; 100(2):312-20. PubMed ID: 26892683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
    Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
    Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
    Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
    Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation, mRNA expression of goat tumor‑associated genes and mRNA expression of DNA methyltransferase in enzootic nasal tumors.
    Quan Z; Ye N; Hao Z; Wen C; Liao H; Zhang M; Luo L; Cao S; Wen X; Wu R; Yan Q
    Mol Med Rep; 2015 Oct; 12(4):6275-85. PubMed ID: 26252527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.
    Eads CA; Danenberg KD; Kawakami K; Saltz LB; Danenberg PV; Laird PW
    Cancer Res; 1999 May; 59(10):2302-6. PubMed ID: 10344733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
    Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
    Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
    Alemayehu A; Sebova K; Fridrichova I
    Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
    Deng G; Chen A; Hong J; Chae HS; Kim YS
    Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
    Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
    Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.
    Yu P; Guo Y; Yusufu M; Liu Z; Wang S; Yin X; Peng G; Wang L; Zhao X; Guo H; Huang T; Liu C
    Cell Biol Int; 2016 Oct; 40(10):1062-70. PubMed ID: 27436059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.